ARTICLE | Company News
Case Western Reserve University, Vision Medicines deal
December 14, 2015 8:00 AM UTC
The university granted Vision exclusive, worldwide rights to VM200, an oral small molecule that is in preclinical testing for Stargardt disease. Vision plans to start a Phase I/II trial next year. Th...